Home/Alaunos Therapeutics/Curtis Hogue

CH

Curtis Hogue

Director

Alaunos Therapeutics

Therapeutic Areas

Metabolic Disorders Oncology

Alaunos Therapeutics Pipeline

Drug	Indication	Phase
Oral Non-Incretin Small Molecule	Obesity & Metabolic Disorders	Pre-clinical
TCR-T Cell Therapies (Platform)	Cancer (Solid Tumors)	Discovery/Platform

Leadership Team at Alaunos Therapeutics

Chair of the Board of Directors, President of Weis Advisors, Inc.

Director, Manager of Brushwood LLC

View full Alaunos Therapeutics profile